*Refresh the page if the below document does not appear.
Biopharma company Akeso Inc. has declared that it is going to partner with Summit Therapeutics Inc. in a deal worth $5 Billion by out-licensing its blockbuster bispecific antibody, ivonescimab (PD-1/VEGF, AK112) for manufacturing and commercialization in the US, Europe, Canada, and Japan.
Healthcare solution providers LifeCell in collaboration with HaystackAnalytics which is a genomics-based health-tech startup announced the launch of a revolutionary genetic test – TB (Omega TB) that will aid in the genetic testing of TB patients.
On Wednesday, the government extended export benefits under the tax refund scheme (RoDTEP) to Pharmaceutical products, steel and iron and chemicals for a certain period of time to increase the export of these goods.
GSK is all set to launch new Shingles Vaccine in India for those who are above 50 years of age. The company has got regulatory approvals from India’s drug regulatory authorities and are planning to launch it in the market next year.
Essential pharma which is an international specialty pharma group announced the acquisition of ‘Haldol’ Decanoate (haloperidol decanoate) from Janssen Pharmaceuticals indicated for the treatment of Schizophrenia and some other psychiatric conditions.
The France-based ANSM drug agency said it is under formal investigation because of suspicion of issuing misleading information concerning Merck’s thyroid drug Levothyrox, adding it challenged the provisional charges.
The Indian Pharmacopoeia Commission (IPC) has flagged a drug safety alert stating that the antibacterial Norfloxacin is related to an adverse reaction known as skin hyperpigmentation.
If you don’t already have an account click the button below to create your account.Create New Account
Please update your profile to keep using the website